Skip to main content
Log in

Studies with heterologous antilymphocytic serum as a therapy for chronic lymphocytic leukemia

  • Published:
Blut Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Libansky, J.: Neoplasma (Bratisl.)6, 621 (1963).

    Google Scholar 

  2. Pfisterer, H., G. Michlmayr, A. D. Tsirimbas, E. Meinzel, H. Bolland, B. Hornung, W. Ruppelt und W. Stich: Dtsch. med. Wschr.93, 2159 (1968).

    Google Scholar 

  3. Pichlmayr, R.: Herstellung und Wirkung heterologer Antilymphozytenseren. Z. ges. exp. Med.143, 161 (1967).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Study of the Association Hematology EURATOM-GSF, contract-no. 031-64-1 BIAD.

Paper presented at the XIIth Congress of the International Society of Hematology, New York 1968.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsirimbas, A.D., Pfisterer, H., Hornung, B. et al. Studies with heterologous antilymphocytic serum as a therapy for chronic lymphocytic leukemia. Blut 19, 420–423 (1969). https://doi.org/10.1007/BF01637327

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01637327

Keywords

Navigation